Episode 094: Heme Consult Series: Cold Agglutinin Disease
The Fellow on Call: The Heme/Onc Podcast
00:00
Advancements in Treating Cold Agglutinin Disease and Complement-Mediated Diseases
Exploring targeted therapies like rituximab and bendamustine, in combination with considerations for patient demographics and alternative treatments like BTK inhibitors. Focus on personalized treatment plans and the approval of satralimab for complement-mediated diseases, blocking the classical complement pathway to prevent hemolysis.
Transcript
Play full episode
